$IRBT
IROBOT CORP

2021 Q2 Form 10-Q Financial Statement

#000115916721000023 Filed on May 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $303.3M $279.9M $192.5M
YoY Change 8.35% 7.58% -18.99%
Cost Of Revenue $180.3M $101.9M $114.6M
YoY Change 77.01% -28.26% -2.99%
Gross Profit $122.9M $178.0M $77.96M
YoY Change -30.93% 50.64% -34.79%
Gross Profit Margin 40.54% 63.6% 40.49%
Selling, General & Admin $74.43M $70.92M $61.17M
YoY Change 4.95% -7.9% -0.93%
% of Gross Profit 60.54% 39.84% 78.46%
Research & Development $41.92M $36.56M $36.76M
YoY Change 14.67% 2.54% 4.22%
% of Gross Profit 34.1% 20.54% 47.15%
Depreciation & Amortization $7.501M $10.30M $7.459M
YoY Change -27.17% 11.96% -14.5%
% of Gross Profit 6.1% 5.79% 9.57%
Operating Expenses $116.6M $107.7M $98.18M
YoY Change 8.19% -4.6% 0.92%
Operating Profit $6.389M $70.28M -$20.23M
YoY Change -90.91% 1238.72% -190.85%
Interest Expense $0.00 -$700.0K -$500.0K
YoY Change -100.0% -36.36% -225.0%
% of Operating Profit 0.0% -1.0%
Other Income/Expense, Net -$160.0K -$384.0K -$19.00K
YoY Change -58.33% -125.05% -101.48%
Pretax Income $6.229M $69.90M -$20.24M
YoY Change -91.09% 930.5% -185.99%
Income Tax -$1.200M $11.30M -$2.109M
% Of Pretax Income -19.26% 16.17%
Net Earnings $7.443M $58.62M -$18.14M
YoY Change -87.3% 713.32% -180.53%
Net Earnings / Revenue 2.45% 20.94% -9.42%
Basic Earnings Per Share $0.26 $2.10 -$0.64
Diluted Earnings Per Share $0.26 $2.07 -$0.64
COMMON SHARES
Basic Shares Outstanding 28.26M shares 27.92M shares 28.30M shares
Diluted Shares Outstanding 29.09M shares 28.28M shares 28.30M shares

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $500.8M $242.3M $263.5M
YoY Change 106.69% 54.53% 31.42%
Cash & Equivalents $500.8M $230.7M $248.8M
Short-Term Investments $0.00 $11.60M $14.80M
Other Short-Term Assets $41.37M $92.56M $41.74M
YoY Change -55.3% 120.58% 36.75%
Inventory $233.1M $133.1M $147.2M
Prepaid Expenses
Receivables $67.92M $128.3M $37.01M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $843.2M $596.2M $489.5M
YoY Change 41.41% 23.92% 4.91%
LONG-TERM ASSETS
Property, Plant & Equipment $80.40M $78.43M $79.53M
YoY Change 2.51% 9.35% 19.39%
Goodwill $123.3M $119.5M $118.4M
YoY Change 3.14% -0.84% 0.71%
Intangibles $9.312M
YoY Change
Long-Term Investments $17.50M $21.70M $21.30M
YoY Change -19.35% 0.46% 12.11%
Other Assets $26.26M $30.94M $33.78M
YoY Change -15.13% 23.26% 44.94%
Total Long-Term Assets $314.7M $324.5M $330.5M
YoY Change -3.02% 1.46% 5.76%
TOTAL ASSETS
Total Short-Term Assets $843.2M $596.2M $489.5M
Total Long-Term Assets $314.7M $324.5M $330.5M
Total Assets $1.158B $920.8M $820.0M
YoY Change 25.75% 14.95% 5.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $150.8M $95.52M $77.22M
YoY Change 57.84% 9.99% -8.82%
Accrued Expenses $105.8M $73.75M $55.80M
YoY Change 43.48% 15.9% 1.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $263.9M $172.8M $138.3M
YoY Change 52.72% 13.24% -4.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $20.71M $12.07M $11.06M
YoY Change 71.66% 38.96% 29.3%
Total Long-Term Liabilities $70.03M $65.93M $65.16M
YoY Change 6.23% -4.26% -9.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $263.9M $172.8M $138.3M
Total Long-Term Liabilities $70.03M $65.93M $65.16M
Total Liabilities $333.9M $238.7M $203.5M
YoY Change 39.88% 7.8% -6.0%
SHAREHOLDERS EQUITY
Retained Earnings $606.8M $492.8M $434.2M
YoY Change 23.14% 24.21% 11.46%
Common Stock $210.2M $184.7M $176.1M
YoY Change 13.78% -0.12% 0.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $824.0M $682.1M $616.5M
YoY Change
Total Liabilities & Shareholders Equity $1.158B $920.8M $820.0M
YoY Change 25.75% 14.95% 5.25%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $7.443M $58.62M -$18.14M
YoY Change -87.3% 713.32% -180.53%
Depreciation, Depletion And Amortization $7.501M $10.30M $7.459M
YoY Change -27.17% 11.96% -14.5%
Cash From Operating Activities $28.69M -$12.50M $40.73M
YoY Change -329.55% -60.19% -22.71%
INVESTING ACTIVITIES
Capital Expenditures $11.27M -$11.70M $7.310M
YoY Change -196.34% 34.48% 21.75%
Acquisitions
YoY Change
Other Investing Activities $8.664M $3.000M $1.560M
YoY Change 188.8% -257.89% -21.09%
Cash From Investing Activities $43.71M -$8.700M -$5.370M
YoY Change -602.39% -17.92% -4.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $25.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$2.167M 2.800M -$25.88M
YoY Change -177.39% 40.0% 456.72%
NET CHANGE
Cash From Operating Activities $28.69M -12.50M $40.73M
Cash From Investing Activities $43.71M -8.700M -$5.370M
Cash From Financing Activities -$2.167M 2.800M -$25.88M
Net Change In Cash $68.12M -18.40M $9.376M
YoY Change -470.21% -54.0% -78.05%
FREE CASH FLOW
Cash From Operating Activities $28.69M -$12.50M $40.73M
Capital Expenditures $11.27M -$11.70M $7.310M
Free Cash Flow $17.42M -$800.0K $33.42M
YoY Change -2277.75% -96.48% -28.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001159167
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-01
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-03
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Entity File Number
EntityFileNumber
001-36414
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
8 Crosby Drive
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
iROBOT CORPORATION
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0259335
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Bedford
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01730
CY2021Q2 dei City Area Code
CityAreaCode
781
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
430-3000
CY2021Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2021Q2 dei Trading Symbol
TradingSymbol
IRBT
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28094994 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
500754000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
432635000 USD
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
51081000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67918000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170526000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
233113000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
181756000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
41369000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
45223000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
843154000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
881221000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80402000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76584000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42086000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43682000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
33408000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
33404000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
123273000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
125872000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9312000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9902000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26256000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19063000 USD
CY2021Q2 us-gaap Assets
Assets
1157891000 USD
CY2021Q1 us-gaap Assets
Assets
1189728000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
150769000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
165779000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
105810000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
131388000 USD
CY2021Q2 us-gaap Deferred Revenue
DeferredRevenue
7294000 USD
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
10400000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
263873000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
307567000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48738000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50485000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
584000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
705000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20712000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
26537000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
70034000 USD
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
77727000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
333907000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
385294000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28395000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28395000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28184000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28184000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
284000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
282000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
209890000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
205256000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
606832000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
599389000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6978000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-493000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
823984000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
804434000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1157891000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1189728000 USD
CY2021Q2 us-gaap Revenues
Revenues
303261000 USD
CY2020Q1 us-gaap Revenues
Revenues
192535000 USD
CY2021Q2 irbt Costofproductrevenue
Costofproductrevenue
180092000 USD
CY2020Q1 irbt Costofproductrevenue
Costofproductrevenue
114295000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
225000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
285000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
180317000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
114580000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
122944000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
77955000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41920000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36759000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
50990000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36594000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23440000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24573000 USD
CY2021Q2 irbt Amortizationof Intangible Assets Nonproduction
AmortizationofIntangibleAssetsNonproduction
205000 USD
CY2020Q1 irbt Amortizationof Intangible Assets Nonproduction
AmortizationofIntangibleAssetsNonproduction
254000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
116555000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
98180000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6389000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-20225000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-160000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6229000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20244000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1214000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2109000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7443000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-18135000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28257000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28297000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29086000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28297000 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7443000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-18135000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-5883000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-914000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
12967000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
5674000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-391000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
1468000 USD
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-4000 USD
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-17000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14914000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14860000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
804434000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2589000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6782000 USD
CY2021Q2 irbt Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount
StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount
4756000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7471000 USD
CY2021Q2 irbt Adjustments To Additional Paid In Capital Directors Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDirectorsDeferredCompensation
21000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7443000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
823984000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
652069000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
934000 shares
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5191000 USD
CY2020Q1 irbt Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount
StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount
1816000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3275000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3275000 USD
CY2020Q1 irbt Adjustments To Additional Paid In Capital Directors Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDirectorsDeferredCompensation
21000 USD
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
25000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-18135000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
616539000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7443000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-18135000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7501000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7459000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6782000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5191000 USD
CY2021Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
95000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
528000 USD
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1582000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1531000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-101459000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-108825000 USD
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
51443000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9848000 USD
CY2021Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3425000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5612000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15438000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-41440000 USD
CY2021Q2 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-32522000 USD
CY2020Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-26405000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28694000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40734000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11272000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7310000 USD
CY2021Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
8664000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1560000 USD
CY2021Q2 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-63644000 USD
CY2020Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-3500000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
43708000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5370000 USD
CY2021Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2589000 USD
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
934000 USD
CY2021Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4756000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1816000 USD
CY2021Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2167000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25882000 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2116000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-106000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
68119000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9376000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
432635000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
239392000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
500754000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
248768000 USD
CY2021Q2 us-gaap Nature Of Operations
NatureOfOperations
Description of BusinessiRobot Corporation ("iRobot" or the "Company") designs and builds robots that empower people to do more. iRobot's consumer robots help people find smarter ways to clean and accomplish more in their daily lives. The Company's portfolio of floor cleaning robots features proprietary technologies for the connected home and advanced concepts in cleaning, mapping and navigation, human-robot interaction and physical solutions. Leveraging this portfolio, the Company's engineers are building an ecosystem of robots to help realize the smart home's potential. The Company’s revenue is primarily generated from product sales through a variety of distribution channels, including chain stores and other national retailers, through the Company's own website and app, dedicated e-commerce websites, the online arms of traditional retailers and through value-added distributors and resellers worldwide.
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000 shares
CY2021Q2 us-gaap Fiscal Period
FiscalPeriod
The Company operates and reports using a 52-53 week fiscal year ending on the Saturday closest to December 31. Accordingly, the Company’s fiscal quarters end on the Saturday that falls closest to the last day of the third month of each quarter.
CY2021Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:5pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenue and expenses. These estimates and judgments include, but are not limited to, revenue recognition, including performance obligations, variable consideration and other obligations such as product returns and incentives; allowance for credit losses; product warranties; valuation of goodwill and acquired intangible assets; valuation of non-marketable equity investments; evaluating loss contingencies; accounting for stock-based compensation including performance-based assessments; and accounting for income taxes and related valuation allowances. The Company bases these estimates and judgments on historical experience, market participant fair value considerations, projected future cash flows and various other factors that the Company believes are reasonable under the circumstances. Actual results may differ from the Company’s estimates.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 3, 2021, the impact of the COVID-19 pandemic remains dynamic and the nature and extent of its full impact on the Company's financial and operational results will depend on several factors, including but not limited to, the duration and severity of the pandemic, advances in treatment and prevention, as well as the macroeconomic impact resulting from global responses to slow the spread of the pandemic. As a result, certain of our estimates and assumptions, including the allowance for credit losses and the valuation of non-marketable equity securities, including our impairment assessment, require increased </span></div>judgment and carry a higher degree of variability and volatility, which could result in material changes to our estimates in future periods.
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-2100000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2700000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4800000 USD
CY2021Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
17500000 USD
CY2021Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
17400000 USD
CY2020Q3 irbt Equitysecuritiesreceivedrestricted
Equitysecuritiesreceivedrestricted
200000 shares
CY2020Q3 us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
38600000 USD
CY2021Q2 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-51500000 USD
CY2021Q2 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
60100000 USD
CY2021Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
8600000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7443000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-18135000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28257000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28297000 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
829000 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29086000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28297000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
13100000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
11500000 USD
CY2021Q2 irbt Refundliabilityproductreturns
Refundliabilityproductreturns
51800000 USD
CY2021Q2 irbt Refundliabilityothercreditsandincentives
Refundliabilityothercreditsandincentives
78300000 USD
CY2021Q1 irbt Refundliabilityproductreturns
Refundliabilityproductreturns
64300000 USD
CY2021Q1 irbt Refundliabilityothercreditsandincentives
Refundliabilityothercreditsandincentives
142200000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
303261000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
192535000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67918000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
14986000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170526000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17700000 USD
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7300000 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3600000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0357
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y1M20D
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1987000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2355000 USD
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
895000 USD
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1122000 USD
CY2021Q2 us-gaap Lease Cost
LeaseCost
2882000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
3477000 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2279000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2021000 USD
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5896000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8590000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7651000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6595000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6621000 USD
CY2021Q2 irbt Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
28562000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
63915000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8955000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
54960000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6222000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48738000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
125872000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9902000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
430000 USD
CY2021Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2599000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
-160000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
123273000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9312000 USD
CY2021Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
23904000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
24392000 USD
CY2021Q2 irbt Accrued Manufacturing And Logistics Costs
AccruedManufacturingAndLogisticsCosts
19374000 USD
CY2021Q1 irbt Accrued Manufacturing And Logistics Costs
AccruedManufacturingAndLogisticsCosts
20093000 USD
CY2021Q2 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
17452000 USD
CY2021Q1 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
17635000 USD
CY2021Q2 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
6817000 USD
CY2021Q1 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
31523000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6222000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6315000 USD
CY2021Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
6136000 USD
CY2021Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
3806000 USD
CY2021Q2 irbt Accrued Sales Tax
AccruedSalesTax
5631000 USD
CY2021Q1 irbt Accrued Sales Tax
AccruedSalesTax
15480000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20274000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12144000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
105810000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
131388000 USD
CY2021Q2 us-gaap Revenues
Revenues
303261000 USD
CY2020Q1 us-gaap Revenues
Revenues
192535000 USD
CY2018Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
200000000.0 USD
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0 USD
CY2020Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
663602 shares
CY2020Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
37.65
CY2020Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
25000000.0 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24392000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13856000 USD
CY2021Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
10185000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
4475000 USD
CY2021Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
10673000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
4333000 USD
CY2021Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
23904000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13998000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.195
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.104
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.195
CY2021Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment

Files In Submission

Name View Source Status
0001159167-21-000023-index-headers.html Edgar Link pending
0001159167-21-000023-index.html Edgar Link pending
0001159167-21-000023.txt Edgar Link pending
0001159167-21-000023-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
irbt-20210403.htm Edgar Link pending
irbt-20210403.xsd Edgar Link pending
irbt-20210403_cal.xml Edgar Link unprocessable
irbt-20210403_def.xml Edgar Link unprocessable
irbt-20210403_htm.xml Edgar Link completed
irbt-20210403_lab.xml Edgar Link unprocessable
irbt-20210403_pre.xml Edgar Link unprocessable
irbtexhibit3114321.htm Edgar Link pending
irbtexhibit3124321.htm Edgar Link pending
irbtexhibit3214321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending